Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knock-out mice lacking 5-HT2A receptors

Journal of Neuroscience

Volumn 25, Issue 49, 2005, Pages 11231-11238

  Popa, Daniela ^a   Léna, Clément ^d   Fabre, Véronique ^a   Prenat, Caroline ^b   Gingrich, Jay ^c   Escourrou, Pierre ^b   Hamon, Michel ^a   Adrien, Joëlle ^a  

^a INSERM   (France)

^b Institut Fédératif de Recherche   (France)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d ECOLE NORMALE SUPÉRIEURE   (France)

Author keywords

5 HT2 receptors; Apnea; Depression; EEG; Knock out mice; Mice; Respiration; Serotonergic; Serotonin; Sleep; Sleep deprivation

Indexed keywords

LIGAND; MESSENGER RNA; RECEPTOR SUBTYPE; SEROTONIN 2 RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APNEA; ARTICLE; BODY PLETHYSMOGRAPHY; BRADYPNEA; BREATHING; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; KNOCKOUT GENE; MALE; MOUSE; NONHUMAN; NONREM SLEEP; PRIORITY JOURNAL; RECEPTOR BLOCKING; RESPIRATION CONTROL; SENSITIVITY ANALYSIS; SLEEP; SLEEP APNEA SYNDROME; SLEEP DEPRIVATION; SLEEP WAKING CYCLE; ADAPTATION; ANIMAL; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENETICS; LUNG VENTILATION; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; WAKEFULNESS;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; MALE; MICE; MICE, KNOCKOUT; PULMONARY VENTILATION; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN, 5-HT2; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SLEEP; SLEEP DEPRIVATION; WAKEFULNESS;

EID: 30544435620     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1724-05.2005     Document Type: Article

References (53)

1. Adrien J, Dugovic C, Martin P (1991) Sleep-wakefulness patterns in the helpless rat. Physiol Behav 49:257-262.
2. Adrien J, Alexandre C, Boutrel B, Popa D (2004) Contribution of the "knock-out" technology to understanding the role of serotonin in sleep regulations. Arch Ital Biol 142:369-377.
3. Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA (2004) Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306:879-881.
4. Benca R (2000) Mooddisorders. In: Principles and practice of sleep medicine (Kryger M, Roth T, Dement W, eds), pp 1140-1158. Philadelphia: Saunders.
5. Benington JH, Heller HC (1995) Monoaminergic and cholinergic modulation of REM-sleep timing in rats. Brain Res 681:141-146.
6. Berendsen HH, Broekkamp CL (1990) Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice. Br J Pharmacol 101:667-673.
7. Bonnier B, Gorwood P, Hamon M, Sarfati Y, Boni C, Hardy-Bayle MC (2002) Association of 5-HT(2A) receptor gene polymorphism with major affective disorders: the case of a subgroup of bipolar disorder with low suicide risk. Biol Psychiatry 51:762-765.
8. Borbely AA, Achermann P (1999) Sleep homeostasis and models of sleep regulation. J Biol Rhythms 14:557-568.
9. Bou-Flores C, Lajard AM, Monteau R, De Maeyer E, Seif I, Lanoir J, Hilaire G (2000) Abnormal phrenic motoneuron activity and morphology in neonatal monoamine oxidase A-deficient transgenic mice: possible role of a serotonin excess. J Neurosci 20:4646-4656.
10. 1B knock-out mice. J Neurosci 19:3204-3212.
11. 1A knock-out mice. J Neurosci 22:4686-4692.
12. Dugovic C, Wauquier A, Leysen JE, Marrannes R, Janssen PA (1989) Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat. Psychopharmacology (Berl) 97:436-442.
13. Dugovic C, Solberg LC, Redei E, Van Reeth O, TurekFW (2000) Sleep in the Wistar-Kyoto rat, a putative genetic animal model for depression. NeuroReport 11:627-631.
14. Duxon MS, Flanigan TP, Reavley AC, Baxter GS, Blackburn TP, Fone KC (1997) Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system. Neuroscience 76:323-329.
15. Fenik P, Veasey SC (2003) Pharmacological characterization of serotonergic receptor activity in the hypoglossal nucleus. Am J Respir Crit Care Med 167:563-569.
16. Fiorica-Howells E, Hen R, Gingrich J, Li Z, Gershon MD (2002) 5-HT(2A) receptors: location and functional analysis in intestines of wild-type and 5-HT(2A) knockout mice. Am J Physiol Gastrointest Liver Physiol 282:G877-G893.
17. Frank MG, Stryker MP, Tecott LH (2002) Sleep and sleep homeostasis in mice lacking the 5-HT2c receptor. Neuropsychopharmacology 27:869-873.
18. Franken P, Malafosse A, Tafti M (1998) Genetic variation in EEG activity during sleep in inbred mice. Am J Physiol 275:R1127-R1137.
19. Franken P, Malafosse A, Tafti M (1999) Genetic determinants of sleep regulation in inbred mice. Sleep 22:155-169.
20. Franken P, Chollet D, Tafti M (2001) The homeostatic regulation of sleep need is under genetic control. J Neurosci 21:2610-2621.
21. Gaspar P, Cases O, Maroteaux L (2003) The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 4:1002-1012.
22. Hilaire G, Morin D, Lajard AM, Monteau R (1993) Changes in serotonin metabolism may elicit obstructive apnoea in the newborn rat. J Physiol (Lond) 466:367-381.
23. Idzikowski C, Mills FJ, James RJ (1991) A dose-response study examining the effects of ritanserin on human slow wave sleep. Br J Clin Pharmacol 31:193-196.
24. Jacky JP (1978) A plethysmograph for long-term measurements of ventilation in unrestrained animals. J Appl Physiol 45:644-647.
25. Jelev A, Sood S, Liu H, Nolan P, Horner RL (2001) Microdialysis perfusion of 5-HT into hypoglossal motor nucleus differentially modulates genioglossus activity across natural sleep-wake states in rats. J Physiol (Lond) 532:467-481.
26. Jouvet M (1969) Biogenic amines and the states of sleep. Science 163:32- 41.
27. Kantor S, Jakus R, Balogh B, Benko A, Bagdy G (2004) Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505. Br J Pharmacol 142:1332-1342.
28. Karashima A, Nakao M, Honda K, Iwasaki N, Katayama N, Yamamoto M (2004) Theta wave amplitude and frequency are differentially correlated with pontine waves and rapid eye movements during REM sleep in rats. Neurosci Res 50:283-289.
29. Kennett G, Lightowler S, Trail B, Bright F, Bromidge S (2000) Effects of RO 60 0175, a 5-HT(2C) receptor agonist, in three animal models of anxiety. Eur J Pharmacol 387:197-204.
30. Kennett GA, Ainsworth K, Trail B, Blackburn TP (1997a) BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats. Neuropharmacology 36:233-239.
31. Kennett GA, Wood MD, Bright F, Trail B, Riley G, Holland V, Avenell KY, Stean T, Upton N, Bromidge S, Forbes IT, Brown AM, Middlemiss DN, Blackburn TP (1997b) SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology 36:609-620.
32. Lauder JM, Wilkie MB, Wu C, Singh S (2000) Expression of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors in the mouse embryo. Int J Dev Neurosci 18:653-662.
33. Lena C, Popa D, Grailhe R, Escourrou P, Changeux JP, Adrien J (2004) β2-containing nicotinic receptors contribute to the organization of sleep and regulate putative micro-arousals in mice. J Neurosci 24:5711-5718.
34. Leysen JE (2004) 5-HT2 receptors. Curr Drug Targets CNS Neurol Disord 3:11-26.
35. Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PF, Laduron PM (1985) Receptor-binding properties in vitro and in vivo of ritanserin: a very potent and long acting serotonin-S2 antagonist. Mol Pharmacol 27:600-611.
36. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402-408.
37. Merahi N, Orer HS, Laguzzi R (1992) 5-HT2 receptors in the nucleus tractus solitarius: characterisation and role in cardiovascular regulation in the rat. Brain Res 575:74 -78.
38. Morishima Y, Shibano T (1995) Evidence that 5-HT2A receptors are not involved in 5-HT-mediated thermoregulation in mice. Pharmacol Biochem Behav 52:755-758.
39. Nakamura A, Kuwaki T (2003) Sleep apnea in mice: a useful animal model for study of SIDS? Early Hum Dev [Suppl] 75:S167-S174.
40. Nakamura A, Fukuda Y, Kuwaki T (2003) Sleep apnea and effect of chemostimulation on breathing instability in mice. J Appl Physiol 94:525-532.
41. Nebigil CG, Choi DS, Dierich A, Hickel P, Le Meur M, Messaddeq N, Launay JM, Maroteaux L (2000) Serotonin 2B receptor is required for heart development. Proc Natl Acad Sci USA 97:9508 -9513.
42. Pace-Schott EF, Hobson JA (2002) The neurobiology of sleep: genetics, cellular physiology and subcortical networks. Nat Rev Neurosci 3:591- 605.
43. Padich RA, McCloskey TC, Kehne JH (1996) 5-HT modulation of auditory and visual sensorimotor gating. II. Effects of the 5-HT2A antagonistMDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats. Psychopharmacology (Berl) 124:107-116.
44. Pena F, Ramirez JM (2002) Endogenous activation of serotonin-2A receptors is required for respiratory rhythm generation in vitro. J Neurosci 22:11055-11064.
45. Reavill C, Kettle A, Holland V, Riley G, Blackburn TP (1999) Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist. Br J Pharmacol 126:572-574.
46. Richerson GB (2004) Serotonergic neurons as carbon dioxide sensors that maintain pH homeostasis. Nat Rev Neurosci 5:449-461.
47. Stutzmann JM, Eon B, Lucas M, Blanchard JC, Laduron PM (1992) RP 62203, a 5-hydroxytryptamine2 antagonist, enhances deep NREM sleep in rats. Sleep 15:119-124.
48. Thase ME (2000) Treatment issues related to sleep and depression. J Clin Psychiatry 61 [Suppl 11]:46 -50.
49. Tobler I, Deboer T, Fischer M (1997) Sleep and sleep regulation in normal and prion protein-deficient mice. J Neurosci 17:1869 -1879.
50. Veasey SC (2003) Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential. Am J Respir Med 2:21-29.
51. Vickers SP, Easton N, Malcolm CS, Allen NH, Porter RH, Bickerdike MJ, Kennett GA (2001) Modulation of 5-HT(2A) receptor-mediated headtwitch behaviour in the rat by 5-HT(2C) receptor agonists. Pharmacol Biochem Behav 69:643-652.
52. Yoshioka M, Goda Y, Togashi H, Matsumoto M, SaitoH (1992) Pharmacological characterization of 5-hydroxytryptamine-induced apnea in the rat. J Pharmacol Exp Ther 260:917-924.
53. Young T (1993) Analytic epidemiology studies of sleep disordered breathing - what explains the gender difference in sleep disordered breathing? Sleep 16:S1-S2.